Unaltered SNARE complex formation in an in vivo model of prion disease

Ayodeji A Asuni1, Colm Cunningham, Piranavhan Vigneswaran

  • 1School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, UK.

Brain Research
|August 19, 2008
PubMed

Insights

Prion disease (PrPSc) accumulation impairs synaptic function but does not disrupt SNARE complex formation essential for neurotransmitter release in the ME7 mouse model. This finding clarifies the mechanism of neurodegeneration in prion diseases.

Area of Science:

  • Neuroscience
  • Prion Biology
  • Molecular Neurodegeneration

Background:

  • Prion diseases cause chronic neurodegeneration, characterized by synaptic dysfunction preceding neuronal death.
  • Misfolded prion protein (PrPSc) accumulation is implicated in synaptic dysfunction.
  • SNARE complexes, crucial for neurotransmitter release, are potentially inhibited by PrPSc.

Purpose of the Study:

  • To investigate the impact of PrPSc deposition on SNARE complex integrity in the ME7 mouse model of prion disease.
  • To determine if PrPSc disrupts SNARE complex formation in vivo, contributing to synaptic dysfunction.

Main Methods:

  • Biochemical analysis of hippocampal tissue from the ME7 prion disease model.
  • Detergent extraction (SDS and Triton X-100) to isolate SNARE complexes.
  • SDS-PAGE to quantify SNARE complex levels.

Main Results:

  • No change in directly SDS-extracted SNARE complexes with increasing PrPSc deposition.
  • A modest reduction in Triton X-100 pre-extracted SNARE complexes at late stages of disease.
  • PrPSc accumulation does not disrupt the formation of core SNARE complexes.

Conclusions:

  • Accumulated PrPSc in the ME7 model does not inhibit the formation of essential SNARE complexes.
  • The synaptic dysfunction observed in prion disease is not caused by PrPSc disrupting SNARE complex formation.
  • PrPSc may inhibit ex vivo formed SNARE complexes, but not the in vivo essential machinery.